Sanchez-Conde M, Vizcarra P, Perez-Garcia JM, Gion M, et al. Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study. Int J Infect Dis 2022 Aug 17. pii: S1201-9712(22)00475.
PMID: 35987472